Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis.
Pak
C Y
CY
Center for Mineral Metabolism & Clinical Research, University of Texas Southwestern Medical Center, Dallas 75235-8885, USA.
Sakhaee
K
K
Rubin
C D
CD
Zerwekh
J E
JE
D001682:Biological Availability; D018849:Controlled Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012969:Sodium Fluoride / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D012969:Sodium Fluoride